Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
26.50    0.00 (0.00%)
Bid:
26.00
Ask:
27.00
Spread: 1.00 (3.846%)
Market Cap: £111.90m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Senior Appointments

22 Jun 2010 07:00

RNS Number : 9692N
Merchant Securities PLC
22 June 2010
 



AIM: MERC

22 June 2010

MERCHANT SECURITIES PLC

("Merchant Securities" or "the Group")

Senior Appointments

Merchant Securities, the financial services group, is pleased to announce two key senior appointments. Lindsay Mair will join the Group's securities business as Head of UK Small Cap Sales & Research and Chris Smith has been appointed as a Senior Executive to establish a research capability in the Financials sector. Both Lindsay Mair and Chris Smith join in September this year.

Lindsay Mair has over 20 years' experience of working within the UK Small/Mid Cap sector. Most recently, he was managing director of Astaire Securities plc. From 2004 to 2009, Lindsay was head of corporate finance at Daniel Stewart & Company plc, where he helped grow its corporate finance business. Prior to this, he worked in advisory and other roles at Corporate Synergy, Sheppards and Citicorp Scrimgeour Vickers. Lindsay qualified as a chartered accountant with Touche Ross in 1986.

Chris Smith has extensive experience as a financials analyst, covering pan-European financial stocks. Latterly, Chris was the senior financials analyst at Jefferies International Limited, having been general financials analyst at Oriel Securities Limited. Chris spent his early career at Barclays de Zoete Wedd Limited as part of the top ranked UK financials team and also worked for HSBC James Capel, where he was the top ranked speciality financials analyst.

These appointments follow the recent enlargement of the Group's institutional equity sales team, with Suzanne Johnson-Walsh joining the sales desk to work alongside head of sales, John Coulson. Suzanne has over 20 years' experience in the UK Smaller Companies market and equity sales. 

Commenting on the appointments, Chief Executive of Merchant Securities, Patrick Claridge, said,

"We have ambitions to develop our institutional sales and research capabilities and these appointments represent an encouraging step forward towards this goal. I am confident that the skills and experience which Lindsay and Chris bring will prove valuable in accelerating the growth of our offering and building our market share." 

For further information, please contact:

 

   

Merchant Securities plc

Patrick Claridge, Chief Executive

  T: 020 7375 9022
     
Arden Partners plc

Richard Day

Matthew Armitt

 

  T: 020 7614 5917
Biddicks

Katie Tzouliadis/Sophie Lane

  T: 020 7448 1000

 

 

About Merchant Securities plc

Based in London, Merchant Securities plc provides a broad range of financial services to private clients, institutions and companies. Specific services include private client investment and wealth management, institutional sales, research and trading, corporate finance and corporate broking.

 

The Group's principal subsidiary, Merchant John East Securities Limited, is authorised and regulated by the Financial Services Authority, a member of the London Stock Exchange and an approved Nominated Adviser to AIM companies.

 

Website: www.merchantjohneast.com 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAPGUAGQUPUGCG
Date   Source Headline
29th Jan 20249:56 amRNSTransaction in Own Shares
26th Jan 20249:03 amRNSTransaction in Own Shares
25th Jan 20249:15 amRNSTransaction in Own Shares
24th Jan 20249:27 amRNSTransaction in Own Shares
23rd Jan 20249:34 amRNSTransaction in Own Shares
22nd Jan 202410:05 amRNSTransaction in Own Shares
19th Jan 202410:01 amRNSTransaction in Own Shares
18th Jan 202410:11 amRNSTransaction in Own Shares
17th Jan 20249:54 amRNSTransaction in Own Shares
16th Jan 202410:50 amRNSTransaction in Own Shares
15th Jan 202410:12 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 202410:40 amRNSTransaction in Own Shares
9th Jan 202410:11 amRNSTransaction in Own Shares
8th Jan 202410:41 amRNSTransaction in Own Shares
5th Jan 20249:46 amRNSTransaction in Own Shares
4th Jan 20249:15 amRNSTransaction in Own Shares
3rd Jan 202410:28 amRNSTransaction in Own Shares
2nd Jan 202411:10 amRNSTransaction in Own Shares
29th Dec 202311:12 amRNSTransaction in Own Shares
28th Dec 202311:01 amRNSTransaction in Own Shares
22nd Dec 20239:24 amRNSTransaction in Own Shares
21st Dec 202311:03 amRNSTransaction in Own Shares
20th Dec 202310:14 amRNSTransaction in Own Shares
19th Dec 20231:53 pmRNSTR-1: Notification of Major Holdings
19th Dec 20239:17 amRNSTransaction in Own Shares
18th Dec 20239:28 amRNSTransaction in Own Shares
15th Dec 20238:56 amRNSTransaction in Own Shares
14th Dec 20238:07 amRNSTransaction in Own Shares
13th Dec 20239:25 amRNSTransaction in Own Shares
12th Dec 202310:25 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
8th Dec 20239:32 amRNSTransaction in Own Shares
7th Dec 202310:34 amRNSTransaction in Own Shares
6th Dec 202310:17 amRNSTransaction in Own Shares
5th Dec 202312:31 pmRNSTransaction in Own Shares
4th Dec 20238:51 amRNSTransaction in Own Shares
30th Nov 20237:00 amRNSDirector/PDMR Dealings
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:58 amRNSTransaction in Own Shares
28th Nov 20237:00 amRNSShare buyback programme
28th Nov 20237:00 amRNSInterim Results
23rd Nov 20237:00 amRNSInvestor Presentation
20th Nov 20237:00 amRNSSale of Mercia’s largest direct investment nDreams
18th Oct 20237:00 amRNSFurther direct investment into Netacea
12th Oct 20237:00 amRNSNotice of Interim Results
21st Sep 202311:05 amRNSResult of AGM
21st Sep 20237:00 amRNSAGM Statement
18th Sep 20234:00 pmRNSGrant of SAYE Options
15th Aug 20237:00 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.